1. Munir, A., S.I. Malik, S. Aslam, A. Mehmood and S. Amjad et al., 2018. Medicinal plants are effective inhibitors of type I and II diabetes. Pharmacophore, 9: 1-7.
   Direct Link  |  
2. Munir, A., S.I. Malik and K.A. Malik, 2018. De-novo ligand design against mutated huntington gene by ligand-based pharmacophore modeling approach. Curr. Compu.-Aided Drug Des. 10.2174/1573409915666181207104437.
   CrossRef  |  Direct Link  |  
3. Munir, A., I.S. Malik and K. Akhtar, 2018. Proteome mining for the identification of putative drug targets for human pathogen clostridium tetani. Curr. Bioinform., 13: 1-8.
4. Malik, R.M., F. Nazir, S. Fazal, M. Ullah and S.I. Malik et al., 2018. Computational analysis of dynamical fluctuations of oncoprotein E7 (HPV) for the hot spot residue identification using elastic network Model. bioRxiv 10.1101/401646.
   CrossRef  |  Direct Link  |  
5. Khan, M.T., S.I. Malik, S. Ali, A.S. Khan, T. Nadeem et al., 2018. Prevalence of pyrazinamide resistance in Khyber Pakhtunkhwa, Pakistan. Microb. Drug Resist., 24: 1417-1421.
   CrossRef  |  Direct Link  |  
6. Khan, M.T., S.I. Malik, A.I. Bhatti, S. Ali and A.S. Khan et al., 2018. Pyrazinamide-resistant mycobacterium tuberculosis isolates from Khyber Pakhtunkhwa and rpsA mutations. J. Biol. Regul. Homeostatic Agents, 32: 705-709.
   PubMed  |  
7. Khan, M.T., M. Junaid, X. Mao, Y. Wang, A. Hussain, S.I. Malik and D.Q. Wei, 2018. Pyrazinamide resistance and mutations L19R, R140H, and E144K in Pyrazinamidase of Mycobacterium tuberculosis. J. Cell. Biochem., 10.1002/jcb.27989.
   CrossRef  |  Direct Link  |  
8. Khan, M.T., A.U. Rehaman, M. Junaid, S.I. Malik and D.Q. Wei, 2018. Insight into novel clinical mutants of RpsA-S324F, E325K and G341R of Mycobacterium tuberculosis associated with pyrazinamide resistance. Comput. Struct. Biotechnol. J., 16: 379-387.
   CrossRef  |  Direct Link  |  
9. Junaid, M., M.T. Khan, S.I. Malik and D.Q. Wei, 2018. Insights into the mechanisms of pyrazinamide resistance of three pyrazinamidase mutants N11K, P69T and D126N. J. Chem. Inform. Model. 27. 10.1021/acs.jcim.8b00525.
   CrossRef  |  Direct Link  |  
10. hwani, M.N., S. Nisar, A. Aleem, M. Panezai, S. Afridi and S.I. Malik, 2017. Amplification of Mitochondrial DNA for detection of plasmodiumvivax in Balochistan. J. Pak. Med. Assoc., 67: 677-681.
    Direct Link  |  
11. Noor, T., S. Zubai, A. Gul and S.I. Malik, 2012. Candidate genes prediction in pakistani families with hearing impairment by using bioinformatics approach. Biosci. J., 28: 1024-1033.
12. Khalid, Z., S. Sameen, S.I. Malik and S. Shehzad, 2012. Computational analysis on the role of GPM6A in human thyroid cancer. J. Data Min. Genom Proteomics, Vol. 3. 10.4172/2153-0602.1000114.
    CrossRef  |  Direct Link  |  
13. Kanwal, S., M. Irfan, S.I. Malik and K. Akhtar, 2012. Comparative homology modeling of human rhodopsin with several templates of bovine rhodopsin. OnLine J. Biotechnol., 11: 466-473.
14. Sameen, S., Z. Khalid and S.I. Malik, 2011. Role of pyruvate dehydrogenase kinases (PDKs) and their respective microRNAs in human ovarian cancer. J. Med. Genet. Genomics, 3: 115-121.
    Direct Link  |  
15. Malik, S.I., Z. Khalid and S. Sameen, 2011. In silico gene expression based analysis on claudin family members association with human thyroid cancer. J. Proteomics Bioinform., 4: 278-283.
    CrossRef  |  Direct Link  |  
16. Malik, S. and S. Khan, 2011. Cancer prevention through employ of appropriate diet in daily schedule. J. Cancer Sci. Ther., Vol. S16. 10.4172/1948-5956.S16-001.
    CrossRef  |  Direct Link  |  
17. Hatzi, V.I., G.I. Terzoudi, C. Stavropoulou, S.I. Malik, V. Makropoulos and G.E. Pantelias, 2011. Lack of association between GSTT1 polymorphism and endogenous or benzo[a]pyrene-induced sister chromatid exchanges as analyzed in metaphase or G2-phase lymphocytes. Mol. Biol. Rep., 38: 3959-3966.
    CrossRef  |  Direct Link  |  
18. Kligerman, A.D., S.I. Malik and J.A. Campbell, 2010. Cytogenetic insights into DNA damage and repair of lesions induced by a monomethylated trivalent arsenical. Mutat. Res./Genet. Toxicol. Environ. Mutagen., 695: 2-8.
    CrossRef  |  Direct Link  |  
19. Malik, S.I., G.I. Terzoudi and G.E. Pantelias, 2004. SCE analysis in G2 lymphocyte prematurely condensed chromosomes after exposure to atrazine: The non-dose-dependent increase in homologous recombinational events does not support its genotoxic mode of action. Cytogenet. Genome Res., 104: 315-319.
    CrossRef  |  Direct Link  |  
20. Terzoudi, G.I., S.I. Malik, G.E. Pantelias, K. Marg, K. Manola and W. Makropoulos, 2003. A new cytogenetic approach for the evaluation of mutagenic potential of chemicals that induce cell cycle arrest in the G_{2 phase. Mutagenesis, 18: 539-543.
    CrossRef  |  Direct Link  |}  
21. Manola, K.N., G.I. Terzoudi, C.E. Dardoufas, S.I. Malik and G.E. Pandelias, 2003. Radioprotective effect of amifostine on cells from cancer prone patients and healthy individuals studied by the G₂ and PCC assays. Int. J. Radiat. Biol., 79: 831-838.
    CrossRef  |  Direct Link  |